Urothelial lesions in Chinese-herb nephropathy
- PMID: 10352187
- DOI: 10.1016/S0272-6386(99)70136-8
Urothelial lesions in Chinese-herb nephropathy
Abstract
Rapidly progressive renal fibrosis after a slimming regimen including Chinese herbs containing aristolochic acid (AA) has been identified as Chinese-herb nephropathy (CHN). We reported urothelial atypia in three patients with CHN, with the subsequent development in one patient of overt transitional cell carcinoma (TCC). Therefore, it was decided to remove the native kidneys, as well as the ureters, in all patients with CHN. Nineteen kidneys and ureters removed during and/or after renal transplantation from 10 patients were studied to assess critically urothelial lesions and to characterize the cellular expression of p53, a tumor-suppressor gene overexpressed in several types of malignancies. Multifocal high-grade flat TCC in situ (carcinoma in situ; CiS) was observed, mainly in the upper urinary tract, in four patients, a prevalence of 40%. In one of those patients, a superficially invasive flat TCC of the right upper ureter, as well as two additional foci of noninvasive papillary TCC, were found in the right pelvis and left lower ureter, respectively. This patient also presented recurrent noninvasive papillary TCC of the bladder. Furthermore, in all cases, multifocal, overall moderate atypia was found in the medullary collecting ducts, pelvis, and ureter. All CiS and papillary TCC, as well as urothelial atypia, overexpressed p53. These results show that the intake of Chinese herbs containing AA has a dramatic carcinogenic effect. Carcinogenesis is associated with the overexpression of p53, which suggests a role for a p53 gene mutation. The relationship of this mutation with the reported presence of AA DNA adducts in the kidney remains to be explored.
Comment in
-
On a nephrotoxic and carcinogenic slimming regimen.Am J Kidney Dis. 1999 Jun;33(6):1171-3. doi: 10.1016/S0272-6386(99)70159-9. Am J Kidney Dis. 1999. PMID: 10352210 No abstract available.
Similar articles
-
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).N Engl J Med. 2000 Jun 8;342(23):1686-92. doi: 10.1056/NEJM200006083422301. N Engl J Med. 2000. PMID: 10841870
-
Urothelial malignant disease and Chinese herbal nephropathy.Lancet. 2001 Nov 3;358(9292):1515-6. doi: 10.1016/s0140-6736(01)06576-x. Lancet. 2001. PMID: 11705569
-
Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy.Cancer Res. 1996 May 1;56(9):2025-8. Cancer Res. 1996. PMID: 8616845
-
Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.Drug Saf. 2003;26(1):33-48. doi: 10.2165/00002018-200326010-00004. Drug Saf. 2003. PMID: 12495362 Review.
-
Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.Semin Nephrol. 2019 May;39(3):284-296. doi: 10.1016/j.semnephrol.2019.02.007. Semin Nephrol. 2019. PMID: 31054628 Review.
Cited by
-
Deciphering the crosstalk between inflammation and biofilm in chronic wound healing: Phytocompounds loaded bionanomaterials as therapeutics.Saudi J Biol Sci. 2024 Apr;31(4):103963. doi: 10.1016/j.sjbs.2024.103963. Epub 2024 Feb 23. Saudi J Biol Sci. 2024. PMID: 38425782 Free PMC article. Review.
-
Toxicological evaluation of a polyherbal formulation on testicular function and gonadal histomorphology in exposed Wistar rats.Biomedicine (Taipei). 2023 Jun 1;13(2):40-47. doi: 10.37796/2211-8039.1404. eCollection 2023. Biomedicine (Taipei). 2023. PMID: 37937303 Free PMC article.
-
Overview of aristolochic acid nephropathy: an update.Kidney Res Clin Pract. 2023 Sep;42(5):579-590. doi: 10.23876/j.krcp.22.211. Epub 2023 Jun 15. Kidney Res Clin Pract. 2023. PMID: 37448287 Free PMC article.
-
Prenatal Developmental Toxicity and Histopathological Changes of the Placenta Induced by Syzygium guineense Leaf Extract in Rats.J Toxicol. 2022 Oct 11;2022:5209136. doi: 10.1155/2022/5209136. eCollection 2022. J Toxicol. 2022. PMID: 36267160 Free PMC article.
-
Mutational signature and clonal relatedness of recurrent urothelial carcinomas with aristolochic acid.Front Oncol. 2022 Sep 14;12:990023. doi: 10.3389/fonc.2022.990023. eCollection 2022. Front Oncol. 2022. PMID: 36185218 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous